ÂÜÀòÂÒÂ×

Mary Nwaneri PharmD currently serves as the Clinical Trial Diversity Head at Daiichi Sankyo, having joined the company in October 2024. Prior to this role, Mary held the position of Director of Health Equity in Clinical Trials at PhRMA from 2021 to 2024. Additional experience includes serving as the Global Labeling Lead for Oncology at Merck and working as a Visiting Scientist in U.S. Regulatory Policy & Strategy and Global Policy & Intelligence at Eli Lilly and Company. Earlier career highlights include a role as Campus Ambassador and Clinical Pharmacology- Oncology Intern at Genentech, as well as managing NIH grants as Lab Manager for Cardiovascular Research at Temple University. Mary Nwaneri holds a Doctorate of Pharmacy from Howard University and a Bachelor of Science in Biology from Allegheny College, and is currently pursuing a degree in Global Health Systems and Public Health at the University of Maryland, Baltimore.